We speculate that the breast cancer tumors with the GSTP1 105Val variant genotype may have different biological characteristics and responses to CTX-based treatment because of altered enzymatic activity, which may ultimately lead to survival differences of patients. Here, GSTP1 is linked to breast carcinoma.